PROCEPT BioRobotics PRCT Cash Flow Statement (2020-2026)

NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT
Reported Financials

PROCEPT BioRobotics Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

PROCEPT BioRobotics reported cash from operations of -$19.25M and free cash flow of -$22.20M for the quarter ended Jun 2026, down 28.0% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-14.27M-18.27M-17.12M-19.32M-23.56M-25.91M-29.26M-26.59M-26.63M-30.68M-28.69M-27.86M-23.57M-20.68M-24.74M-19.58M-24.11M-31.93M-31.64M-26.86M
Share-based CompensationStock Comp.
0.93M1.50M1.55M2.68M18.44M0.19M3.72M5.10M5.33M4.98M6.26M7.99M8.51M9.09M10.11M12.16M14.49M10.84M13.07M14.53M
Gains from Investment SecuritiesGains Investment
-0.02M-0.04M
Asset Writedowns and ImpairmentWritedown
0.11M0.09M-0.03M0.23M0.19M0.58M0.91M0.38M0.60M0.33M0.57M0.53M-0.86M0.27M0.43M
Cash from OperationsCash from Ops.
-12.75M-16.48M-18.23M-17.13M-19.85M-25.17M-35.93M-28.34M-18.94M-24.79M-32.29M-15.74M-18.80M-32.39M-16.98M-15.04M-6.63M-10.33M-38.13M-19.25M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.80M0.76M0.76M0.72M0.70M0.66M0.79M0.64M1.05M1.32M1.18M1.27M1.33M1.45M1.48M1.59M1.62M1.71M1.74M1.99M
Change in Working Capital
Change in ReceivablesChange Receivables
1.21M-1.89M2.53M3.90M1.95M2.43M5.37M12.53M1.45M13.75M7.71M2.83M10.59M14.83M-3.93M2.71M4.35M-2.23M13.32M11.63M
Change in InventoryChange Inventory
0.82M2.54M-0.52M1.20M8.82M5.75M10.14M3.29M-0.48M-3.19M1.49M2.79M7.16M5.80M6.28M4.79M-0.57M4.00M7.03M-0.20M
Change in Account PayablesChange Payables
0.24M-1.55M0.45M0.50M3.30M-0.28M2.23M0.01M-2.32M5.88M-2.31M0.34M5.19M-5.38M3.75M-2.25M-0.79M5.93M1.54M-2.85M
Change in Accured ExpensesChange Accured Exp.
-0.89M1.68M-1.89M2.39M3.31M3.16M-6.04M2.54M3.82M3.12M-5.42M3.41M3.95M2.70M-6.56M1.31M5.46M1.66M-4.69M1.96M
Other Working Capital ChangesOther WC Changes
0.18M0.18M0.34M0.49M0.48M0.51M1.09M1.13M0.45M0.65M0.20M0.65M1.44M1.42M0.23M-0.01M1.13M1.95M0.63M0.36M
Investing Activities
Capital ExpendituresCapex
0.03M0.33M0.35M0.21M1.22M1.76M5.34M5.37M5.78M8.71M1.95M1.04M0.25M1.17M1.84M2.80M2.87M1.85M2.91M2.95M
Cash from Investing ActivitiesCash from Investing
-0.11M-0.33M-0.06M-0.22M-1.51M-0.87M-5.34M-5.37M-5.78M-8.71M-1.95M-1.04M-0.25M-1.17M-1.84M-2.80M-2.87M-1.85M-2.91M-2.95M
Financing Activities
Other financing activitiesOther financing
169.77M-0.04M1.29M1.57M0.78M0.37M0.38M0.71M0.41M0.97M2.59M3.17M1.72M3.60M1.30M0.87M1.08M1.58M0.22M0.18M
Cash from Financing ActivitiesCash from Financing
174.12M0.64M1.29M2.86M0.78M-1.32M0.38M2.43M162.12M2.87M2.59M5.30M1.72M170.53M1.30M4.38M1.08M4.44M0.22M4.50M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
-1.29M164.52M
Additional items
Exchange Rate EffectFX Effect
-0.02M-0.01M-0.04M-0.04M-0.02M
Change in Cash
161.26M-16.16M-17.00M-14.48M-20.59M-27.36M-40.89M-31.28M137.40M-30.64M-31.65M-11.48M-17.33M136.96M-17.52M-13.49M-8.44M-7.78M-40.86M-17.73M
Free Cash FlowFCF
-12.79M-16.81M-18.58M-17.34M-21.07M-26.93M-41.27M-33.71M-24.72M-33.51M-34.23M-16.78M-19.05M-33.56M-18.82M-17.84M-9.50M-12.18M-41.04M-22.20M
Net Cash FlowNCF
161.26M-16.16M-17.00M-14.48M-20.59M-27.36M-40.89M-31.28M137.40M-30.64M-31.65M-11.48M-17.33M136.96M-17.52M-13.47M-8.43M-7.74M-40.82M-17.71M